International Journal of Cancer Management

Published by: Kowsar

Positive Peritoneal Cytology as a Predictor of Prognosis in Early Stage of Endometrioid Adenocarcinoma

Setare Akhavan 1 , Zohre Kazemi 1 , Abbas Alibakhshi 2 , Mitra Modaresgilani 1 , Azamsadat Mousavi 1 , Azar Ahmadzadeh 1 and Khadije Rezaie Kahkhayi 1
Authors Information
1 Department of Gynecologic Oncology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of General Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Warning: No corresponding author defined!
Article information
  • Iranian Journal of Cancer Prevention: February 2017, 10 (2); e5285
  • Published Online: February 18, 2017
  • Article Type: Research Article
  • Received: January 4, 2016
  • Revised: January 22, 2016
  • Accepted: February 11, 2017
  • DOI: 10.5812/ijcp.5285

To Cite: Akhavan S, Kazemi Z, Alibakhshi A, Modaresgilani M, Mousavi A, et al. Positive Peritoneal Cytology as a Predictor of Prognosis in Early Stage of Endometrioid Adenocarcinoma, Int J Cancer Manag. 2017 ; 10(2):e5285. doi: 10.5812/ijcp.5285.

Copyright © 2017, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1): 11-30[DOI][PubMed]
  • 2. Albertini AF, Devouassoux-Shisheboran M, Genestie C. Pathology of endometrioid carcinoma. Bull Cancer. 2012; 99(1): 7-12[DOI][PubMed]
  • 3. S. G. O. Clinical Practice Endometrial Cancer Working Group , Burke WM, Orr J, Leitao M, Salom E, Gehrig P, et al. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014; 134(2): 385-92[DOI][PubMed]
  • 4. Ranjbar R, Nejatollahi F, Nedaei Ahmadi AS, Hafezi H, Safaie A. Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance. Iran J Cancer Prev. 2015; 8(4)[DOI][PubMed]
  • 5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2): 71-96[DOI][PubMed]
  • 6. Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, et al. Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst. 1997; 89(15): 1110-6[PubMed]
  • 7. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 2006; 106(11): 2376-81[DOI][PubMed]
  • 8. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994; 86(7): 527-37[PubMed]
  • 9. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612): 569-78[DOI][PubMed]
  • 10. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension. 1999; 34(2): 320-5[PubMed]
  • 11. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol. 1984; 64(3): 417-20[PubMed]
  • 12. Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005; 105(3): 575-80[DOI][PubMed]
  • 13. McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996; 143(12): 1195-202[PubMed]
  • 14. Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med. 2008; 121(6): 501-508 e3[DOI][PubMed]
  • 15. Patrelli TS, Berretta R, Rolla M, Vandi F, Capobianco G, Gramellini D, et al. Pelvic lymphadenectomy in endometrial cancer: our current experience. Eur J Gynaecol Oncol. 2009; 30(5): 536-8[PubMed]
  • 16. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40(1): 55-65[PubMed]
  • 17. Berretta R, Merisio C, Piantelli G, Rolla M, Giordano G, Melpignano M, et al. Preoperative transvaginal ultrasonography and intraoperative gross examination for assessing myometrial invasion by endometrial cancer. J Ultrasound Med. 2008; 27(3): 349-55[PubMed]
  • 18. Rakhsha A, Yousefi Kashi AS, Hoseini SM. Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix. Iran J Cancer Prev. 2015; 8(4)[DOI][PubMed]
  • 19. Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Mod Pathol. 2002; 15(4): 365-71[DOI][PubMed]
  • 20. Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A, et al. Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma. Am J Clin Pathol. 2008; 129(6): 912-7[DOI][PubMed]
  • 21. Merisio C, Berretta R, De Ioris A, Pultrone DC, Rolla M, Giordano G, et al. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol. 2005; 122(1): 107-11[DOI][PubMed]
  • 22. Berretta R, Patrelli TS, Migliavacca C, Rolla M, Franchi L, Monica M, et al. Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer. Oncol Rep. 2014; 31(5): 2407-12[DOI][PubMed]
  • 23. Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol. 2000; 44(5): 783-9[PubMed]
  • 24. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol. 1989; 74(5): 775-80[PubMed]
  • 25. Hanson MB, van Nagell JJ, Powell DE, Donaldson ES, Gallion H, Merhige M, et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer. 1985; 55(8): 1753-7[PubMed]
  • 26. Garg G, Gao F, Wright JD, Hagemann AR, Zighelboim I, Mutch DG, et al. The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer. Int J Gynecol Cancer. 2013; 23(1): 90-7[DOI][PubMed]
  • 27. Momayyezi M, Fallahzadeh H, Momayyezi M. Construction and Validation the Lifestyle Questionnaire Related to Cancer. Iran J Cancer Prev. 2015; 8(5)[DOI][PubMed]
  • 28. Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol. 2005; 18(5): 673-80[DOI][PubMed]
  • 29. Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003; 88(2): 245-50[DOI][PubMed]
  • 30. Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer. Gynecol Oncol. 2013; 128(1): 77-82[DOI][PubMed]
  • 31. Milgrom SA, Kollmeier MA, Abu-Rustum NR, Makker V, Gardner GJ, Barakat RR, et al. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecol Oncol. 2013; 130(1): 49-53[DOI][PubMed]
  • 32. Kadar N, Homesley HD, Malfetano JH. Prognostic factors in surgical stage III and IV carcinoma of the endometrium. Obstet Gynecol. 1994; 84(6): 983-6[PubMed]
  • 33. Takeshima N, Nishida H, Tabata T, Hirai Y, Hasumi K. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol. 2001; 82(3): 470-3[DOI][PubMed]
  • 34. Garg G, Morris RT, Solomon L, Toy EP, Kruger M, Clary K, et al. Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Gynecol Oncol. 2011; 123(2): 208-13[DOI][PubMed]
  • 35. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105(2): 103-4[PubMed]
  • 36. Preyer O, Obermair A, Formann E, Schmid W, Perrin LC, Ward BG, et al. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol. 2002; 86(3): 269-73[PubMed]
  • 37. Havrilesky LJ, Cragun JM, Calingaert B, Alvarez Secord A, Valea FA, Clarke-Pearson DL, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007; 104(2): 401-5[DOI][PubMed]
  • 38. Li M, Wang Z, Zhao L, Li X, Wang J, Zhang C, et al. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma]. Zhonghua Fu Chan Ke Za Zhi. 2014; 49(6): 455-9[PubMed]
  • 39. Kato R, Hasegawa K, Torii Y, Hirasawa Y, Udagawa Y, Fukasawa I. Cytological scoring and prognosis of poorly differentiated endometrioid adenocarcinoma. Acta Cytol. 2015; 59(1): 83-90[DOI][PubMed]
  • 40. McLellan R, Dillon MB, Currie JL, Rosenshein NB. Peritoneal cytology in endometrial cancer: a review. Obstet Gynecol Surv. 1989; 44(10): 711-9[PubMed]
  • 41. Grimshaw RN, Tupper WC, Fraser RC, Tompkins MG, Jeffrey JF. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol. 1990; 36(1): 97-100[PubMed]
  • 42. Lurain JR, Rumsey NK, Schink JC, Wallemark CB, Chmiel JS. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1989; 74(2): 175-9[PubMed]
  • 43. Saga Y, Imai M, Jobo T, Kuramoto H, Takahashi K, Konno R, et al. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol. 2006; 103(1): 277-80[DOI][PubMed]
  • 44. Bansal S, Buck AM, Herzog TJ, Deutsch I, Burke WM, Wright JD. Stage IIIA endometrial carcinoma: outcome and predictors of survival. Obstet Gynecol. 2009; 114(1): 100-5[DOI][PubMed]
  • 45. Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, et al. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. Gynecol Oncol. 2015; 136(2): 235-9[DOI][PubMed]
  • 46. Binesh F, Akhavan A, Behniafard N, Zabihi S, Hosseinizadeh E. Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue. Asian Pac J Cancer Prev. 2014; 15(21): 9405-10[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments